We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Radiation recall dermatitis induced by tamoxifen during adjuvant breast cancer treatment.
- Authors
Jiyoung Rhee; Gwi Eon Kim; Chang Hyun Lee; Jung-Mi Kwon; Sang-Hoon Han; Young Suk Kim; Woo-Kun Kim
- Abstract
Tamoxifen and radiotherapy are used in breast cancer treatment worldwide. Radiation recall dermatitis (RRD), induced by tamoxifen, has been rarely reported. Herein, we report a RRD case induced by tamoxifen. A 47-year-old woman had a right quadrantectomy and an axillary lymph node dissection due to breast cancer. The tumor was staged pT2N0; it was hormone receptor positive, and human epidermal growth factor receptor 2 negative. The patient received adjuvant chemotherapy followed by tamoxifen and radiotherapy. After 22 months of tamoxifen, the patient developed a localized heating sensation, tenderness, edema, and redness at the irradiated area of the right breast. The symptoms improved within 1 week without treatment. Three weeks later, however, the patient developed similar symptoms in the same area of the breast. She continued tamoxifen before and during dermatitis, and symptoms resolved within 1 week.
- Subjects
BREAST cancer treatment; TAMOXIFEN; RADIOTHERAPY
- Publication
Radiation Oncology Journal, 2014, Vol 32, Issue 4, p262
- ISSN
2234-1900
- Publication type
Case Study
- DOI
10.3857/roj.2014.32.4.262